10x Genomics (TXG) insider trading in the last 6 months

Form 4 filings, newest first

Quality Score today 3

4 insiders sold $6.2M. No buys.

SellJohn R. Stuelpnagel$425KDirectorat $60.66 on Sep 3, filed Sep 8

SellJohn R. StuelpnagelDirector$425Kat $60.66 on Sep 3, filed Sep 8

SellJohn R. Stuelpnagel$423KDirectorat $62.11 on Sep 3, filed Sep 8

SellJohn R. StuelpnagelDirector$423Kat $62.11 on Sep 3, filed Sep 8

SellJohn R. Stuelpnagel$387KDirectorat $62.61 on Sep 3, filed Sep 8

SellJohn R. StuelpnagelDirector$387Kat $62.61 on Sep 3, filed Sep 8

From SEC Form 4s, the newest filed Sep 8, 2026 · Insiders have 2 business days to file a trade

7 more filings on TXG in the last 6 months, for Pro members. See them free →

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 10 tradesSee it live, free until Tuesday morning. No account. No card. Then keep going with a free account.

Pro members see every filing on TXG with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at 10x Genomics

Insider trades by person

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Questions about TXG's insider trades

As of Nov 7, 2026: 10x Genomics (TXG) has 10 insider filings on record in the last 6 months, the newest filed Sep 8, 2026. Its Quality Score is 3 (Below Average). Scores as of 12:47 PM ET, 15 minutes behind.

Are TXG insiders buying or selling?

4 insiders sold $6.2M across 10 filings in the last 6 months. No open-⁠market buys on record. The newest filing: John R. Stuelpnagel, Director, sold $425K on Sep 3, 2026.

Who are TXG's biggest insider sellers?

By the dollars of their sales in the last 6 months: John R. Stuelpnagel (Director), 5 sales; Adam Taich (Chief Financial Officer), 2 sales; Serge Saxonov (Chief Executive Officer), 1 sale. 4 insiders sold in all.

When did a TXG insider last buy?

No TXG insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by John R. Stuelpnagel on Sep 3, 2026.

10x Genomics's page has its Quality Score, its chart, and its earnings. More in Healthcare and Laboratory Analytical Instruments.